Malignant Neoplasm Clinical Trials in Houston, Texas

10 studies are recruiting for malignant neoplasm in Houston, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

   Researchers are looking for new ways to treat children with hepatoblastoma or rhabdomyosarcoma (RMS) that has relapsed or is refractory: * Hepatoblastoma is a common liver cancer in babies and very young children * RMS is a cancer that starts in muscle cells, often in a child's head and neck, bladd…

   Stage

   Phase 1

   Ages

   0 to 17

   Site

   University of Texas-MD Anderson Cancer Center ( Site 3007), Houston, Texas

   Locations

   63 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06941272 on ClinicalTrials.gov

2. A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)

   Researchers are looking for new ways to treat children with relapsed or refractory solid tumors: * Relapsed means the cancer came back after treatment * Refractory means the cancer did not respond (get smaller or go away) to treatment * Solid tumors are cancers mostly in body organs and tissues, no…

   Stage

   Phase 1

   Ages

   0 to 17

   Site

   University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston, Texas

   Locations

   26 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT07630974 on ClinicalTrials.gov

3. A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

   Researchers are looking for new ways to treat people with certain advanced solid tumors. Advanced means the cancer has spread to other parts of the body and cannot be removed with surgery. Solid tumors are cancers mostly in body organs and tissues, not in the blood or other body liquids. The main g…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   NEXT Oncology ( Site 1011), Houston, Texas

   Locations

   49 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06818643 on ClinicalTrials.gov

4. Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

   This phase II trial studies how well donor cytotoxic T lymphocytes work in treating patients with malignancies with BK and/or JC virus. Cytotoxic T lymphocytes are made from donated blood cells that are grown in the laboratory and are designed to kill viruses that can cause infections in transplant…

   Stage

   Phase 2

   Ages

   Any age

   Site

   M D Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT02479698 on ClinicalTrials.gov

5. A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

   Researchers want to learn if MK-5684 (the study medicine) can treat breast cancer, ovarian cancer, and endometrial cancer. MK-5684, the study medicine, is designed to treat cancer by blocking the body from making steroid hormones. Researchers will compare MK-5684 to the standard treatments for each…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Baylor College of Medicine Medical Center ( Site 0004), Houston, Texas

   Locations

   59 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06979596 on ClinicalTrials.gov

6. Project: Every Child for Younger Patients With Cancer

   This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

   Stage

   Not phased

   Ages

   Up to 25

   Site

   Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas

   Locations

   279 in total

   Run by

   Children's Oncology Group

   See if you can join NCT02402244 on ClinicalTrials.gov

7. New Assessment System in Measuring Symptom Distress in Cancer Patients

   This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in…

   Stage

   Not phased

   Ages

   18 and older

   Site

   M D Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT00505245 on ClinicalTrials.gov

8. Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

   The main goal of this phase of the study is to determine if objectively assessed Physical Activity (PA) levels in advanced-cancer patients are associated with health care provider (HCP)-assessed ECOG performance status and overall survival. The purpose is to advance the evidence-base for incorporat…

   Stage

   Not phased

   Ages

   18 and older

   Site

   M D Anderson Cancer Center, Houston, Texas

   Run by

   M.D. Anderson Cancer Center

   See if you can join NCT01365169 on ClinicalTrials.gov

9. Molecular Genetics Studies of Cancer Patients and Their Relatives

   This trial studies the genetic and behavioral factors that may contribute to the development of specific cancers and how these factors may affect the outcome of the disease in patients with a history of cancer and their relatives.

   Stage

   Not phased

   Ages

   Any age

   Site

   Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas

   Locations

   42 in total

   Run by

   City of Hope Medical Center

   See if you can join NCT04185935 on ClinicalTrials.gov

10. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    The study is a first-in-human (FIH), open-label, multi-center phase 1/2 study of TSN1611 in subjects with KRAS G12D mutant advanced solid tumors. This study will consist of a phase 1 dose escalation part and phase 2 dose expansion part. This study will evaluate the efficacy of TSN1611 at RP2D(s) th…

    Stage

    Phase 1

    Ages

    18 to 75

    Site

    MD Anderson Cancer Center, Houston, Texas

    Locations

    19 in total

    Run by

    Tyligand Pharmaceuticals (Suzhou) Limited

    See if you can join NCT06385925 on ClinicalTrials.gov